Abstract
The neurotrophins are a family of closely related proteins that were first identified as survival factors for sympathetic and sensory neurons and have since been shown to control a number of aspects of survival, development, and function of neurons in both the central and peripheral nervous systems. Limiting quantities of neurotrophins during development control the numbers of surviving neurons to ensure a match between neurons and the requirement for a suitable density of target innervation. Biological effects of each of the four mammalian neurotrophins are mediated through activation of one or more of the three members of the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB, and TrkC). In addition, all neurotrophins activate the p75 neurotrophin receptor, a member of the tumor necrosis factor receptor superfamily. Neurotrophin engagement of Trk receptors leads to activation of Ras, phosphatidylinositol 3-kinase, phospholipase C-γ1, and signaling pathways controlled through these proteins, including the mitogen-activated protein kinases. Neurotrophin availability is required into adulthood, where they control synaptic function and plasticity and sustain neuronal cell survival, morphology, and differentiation. This chapter will provide an overview of neurotrophin biology, their receptors, and signaling pathways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science 237, 1154–1162
Hamburger V, and Levi-Montalcini R (1949) Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 111, 457–501
Dreyfus CF (1989) Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol Sci 10, 145–149
Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270, 593–598
Ginty DD, and Segal RA (2002) Retrograde neurotrophin signaling: Trk-ing along the axon. Curr Opin Neurobiol 12, 268–274
Barde Y-A (1989) Trophic factors and neuronal survival. Neuron 2, 1525–1534
Bothwell M (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18, 223–253
Skaper SD (2008) The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS & Neurol Disorders – Drug Targets 7, 46–62
Oppenheim RW (1991) Cell death during development of the nervous system. Annu Rev Neurosci 14, 453–501
Barde Y-A, Edgar D, and Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1, 549–553
Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, et al (1994) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149–152
Ibáñez CF (1995) Neurotrophic factors: from structure-function studies to designing effective therapeutics. Trends Biotech 13, 217–227
Berkemeier LR, Winslow JW, Kaplan DR, Nicolics K, Goeddel DV, and Rosenthal A (1991) Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7, 857–866
Hallböök F, Ibáñez CF, and Persson H (1991) Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6, 845–858
Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ, Fandl J, et al. (1993) Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 10, 137–149
Götz R, Köster R, Winkler C, Raulf F, Lottspeich F, Schartl M, et al. (1994) Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372, 266–269
Lai KO, Fu WY, Ip FCF, and Ip NY (1998) Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol Cell Neurosci 11, 64–76
Eide FF, Lowenstein DH, and Reichardt LF (1993) Neurotrophins and their receptors-current concepts and implications for neurologic disease. Exp Neurol 121, 200–214
Wiesmann C, Ultsch MH, Bass SH, and de Vos AM (1999) Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–188
McDonald NQ, Lapatto R, Murray-Rust J, Gunning J, Wlodawer A, and Blundell TL (1991) New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature 354, 411–414
Robinson RC, Radziejewski C, Stuart DI, and Jones EY (1995) Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. Biochemistry 34, 4139–4146
Robinson RC, Radziejewski C, Spraggon G, Greenwald J, Kostura MR, Burtnick LD, et al (1999) The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site. Protein Sci 8, 2589–2597
Lindsay RM, and Yancopoulos GD (1996) GDNF in a bind with known orphan: accessory implicated in new twist. Neuron 17, 571–574
Barde Y-A (1994) Neurotrophic factors: an evolutionary perspective. J Neurobiol 25, 1329–1333
Kullander K, Carlson B, and Hallböök FJ (1997) Molecular phylogeny and evolution of the neurotrophins from monotremes and marsupials. Mol Evol 45, 311–321
Butte MJ (2001) Neurotrophic factor structures reveal clues to evolution, binding, specificity, and receptor activation. Cell Mol Life Sci 58, 1003–1013
Ip NY, and Yancopoulos GD (1996) The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Annu Rev Neurosci 19, 491–415
Doré S, Kar S, and Quirion R (1997) Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases. Trends Neurosci 20, 326–331
Walicke P, Cowan WM, Ueno N, Baird A, and Guillemin R (1986) Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc Natl Acad Sci USA 83, 3012–3016
Farkas LM, Dünker N, Roussa E, Unsicker K, and Krieglstein K (2003) Transforming growth factor-βs are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. J Neurosci 23, 5178–5186
Miao N, Wang M, Ott JA, D’Alessandro JS, Woolf TM, Bumcrot DA, et al (1997) Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult in vitro. J Neurosci 17, 5891–5899
Radeke MJ, Misko TP, Hsu C, Herzenberg LA, and Shooter E (1987) Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 325, 593–597
Rodriguez-Tébar A, Dechant G, and Barde Y-A (1990) Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 4, 487–492
Rodríguez-Tébar A, Dechant G, Götz R, and Barde Y-A (1992) Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J 11, 917–922
He XE, and Garcia KC (2004) Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304, 870–875
Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, and Parada LF (1991) The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 252, 554–558
Klein R, Jing SQ, Nanduri V, O’Rourke E, and Barbacid M (1991) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65, 189–197
Klein R, Nanduri V, Jing SA, Lambelle F, Tapley P, Bryant S, et al (1991) The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66, 395–403
Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, et al (1991) trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65, 885–893
Lamballe F, Klein R, and Barbacid M (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66, 967–979
Benedetti M, Levi A, and Chao MV (1993) Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci USA 90, 7859–7863
Bibel M, Hoppe E, and Barde Y-A (1999) Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J 18, 616–622
Mahadeo D, Kaplan L, Chao MV, and Hempstead BL (1994) High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. J Biol Chem 269, 6884–6891
Esposito D, Patel P, Stephens RM, Perez P, Chao MV, Kaplan DR, et al (2001) The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem 276, 32687–32695
Curtis R, Adryan KM, Stark JL, Park JS, Compton DL, Weskamp G, et al (1995) Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron 14, 1201–1211
Makkerh JP, Ceni C, Auld DS, Vaillancourt F, Dorval G, and Barker PA (2005) p75 neurotrophin receptor reduces ligand-induced Trk receptor ubiquitination and delays Trk receptor internalization and degradation. EMBO J 6, 936–941
Geetha T, Jiang J, and Wooten MW (2005) Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling. Mol Cell 20, 301–312
Bentley CA, and Lee KF (2000) p75 is important for axon growth and schwann cell migration during development. J Neurosci 20, 7706–7715
Harrison SMW, Jones ME, Uecker S, Albers KM, Kudrycki KE, and Davis BM (2000) Levels of nerve growth factor and neurotrophin-3 are affected differentially by the presence of p75 in sympathetic neurons in vivo. J Comp Neurol 424, 99–110
Lee K-F, Li E, Huber LJ, Landis SC, Sharpe AH, Chao MV, et al (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749
Lee KF, Bachman K, Landis S, and Jaenisch R (1994) Dependence on p75 for innervation of some sympathetic targets. Science 263, 1447–1449
Stucky CL, and Koltzenburg M (1997) The low-affinity neurotrophin receptor p75 regulates the function but not the selective survival of specific subpopulations of sensory neurons. J Neurosci 17, 4398–4405
Ultsch MH, Wiesmann C, Simmons LC, Henrich J, Yang M, Reilly D, et al (1999) Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC. J Mol Biol 290, 149–159
Urfer R, Tsoulfas P, O’Connell L, Hongo JA, Zhao W, and Presta LG (1998) High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors. J Biol Chem 273, 5829–5840
Weiss A, and Schlessinger J (1998) Switching signals on or off by receptor dimerization. Cell 94, 277–280
Huang EJ, and Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72, 609–642
Lee R, Kermani P, Teng KK, and Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948
Segal RA, and Greenberg ME (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19, 463–489
York RD, Molliver DC, Grewal SS, Stenberg PE, McCleskey EW, Stork PJS (2000) Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1. Mol Cell Biol 20, 8069–8083
Daub H, Weiss FU, Wallasch C, and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557–560
Luttrell LM, Daaka Y, and Lefkowitz RJ (1999) Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11, 177–180
Lee FS, and Chao MV (2001) Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci USA 98, 3555–3560
Lee FS, Rajagopal R, Kim AH, Chang PC, and Chao MV (2002) Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J Biol Chem 277, 9096–9102
Rajagopal R, Chen ZY, Lee FS, and Chao MV (2004) Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24, 6650–6658
Rajagopal R, and Chao MV (2006) A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. Mol Cell Neurosci 33, 36–46
Sofroniew MV, Howe CL, and Mobley WC (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24, 1217–1281
Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4, 299–309
Lu B, Pang PT, and Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6, 603–614
Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Phil Trans Royal Soc B 361, 1545–1564
Hefti F (1986) Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transactions. J Neurosci 6, 2155–2162
Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, et al (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transaction. Proc Natl Acad Sci USA 83, 9231–9235
Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290, 767–773
Yasuda T, and Mochizuki H (2010) Use of growth factors for the treatment of Parkinson’s disease. Expert Rev Neurother 10, 915–924
Podulso JF, Curran GL, and Gill JS (1998) Putrescine-modified nerve growth factor: bioactivity, plasma pharmacokinetics, blood-brain/nerve barrier permeability, and nervous system biodistribution. J Neurochem 71, 1651–1660
Wu D, and Pardridge WM (1999) Neuroprotection with noninvasive neurotrophin delivery to the brain. Proc Natl Acad Sci USA 96, 254–259
Zhang Y, and Pardridge WM (2001) Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke 32, 1378–1384
Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, et al (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838–841
Zhou L, Baumgartner BJ, Hill-Felberg SJ, McGowen LR, and Shine HD (2003) Neurotrophin-3 expressed in situ induces axonal plasticity in the adult injured spinal cord. J Neurosci 23, 1424–1431
Blesch A, Yang H, Weidner N, Hoang A, and Otero D (2004) Axonal responses to cellularly delivered NT-4/5 after spinal cord injury. Mol Cell Neurosci 27, 190–201
Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, et al (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11, 551–555
Qu HY, Zhang T, Li XL, Zhou JP, Zhao BQ, Li Q, et al (2008) Transducible P11-CNTF rescues the learning and memory impairments induced by amyloid-beta peptide in mice. Eur J Pharmacol 594, 93–100
Garcia P, Youssef I, Utvik JK, Florent-Béchard S, Barthélémy V, Malaplate-Armand C, et al (2010) Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer’s disease. J Neurosci 30, 7516–7527
Brewster WJ, Fernyhough P, Diemel LT, Mohiuddin L, and Tomlinson RR (1994) Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 17, 321–325
Apfel SC (2002) Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Internatl Rev Neurobiol 50, 393–413
Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, and Rask CA (1998) Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 51, 695–702
McArthur JC, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, et al (2000) A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 54, 1080–1088
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Skaper, S.D. (2012). The Neurotrophin Family of Neurotrophic Factors: An Overview. In: Skaper, S. (eds) Neurotrophic Factors. Methods in Molecular Biology, vol 846. Humana Press. https://doi.org/10.1007/978-1-61779-536-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-61779-536-7_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-535-0
Online ISBN: 978-1-61779-536-7
eBook Packages: Springer Protocols